| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $4.2B | $4.9B | $5.0B | $3.3B | $2.9B | $1.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | — |
| Operating Income | $-0.1B | $0.4B | $1.1B | $1.4B | $0.4B | $-1.7B | $-0.2B | — |
| Net Income | $-0.0B | $0.4B | $0.8B | $1.3B | $0.4B | $-1.9B | $-0.3B | — |
| EPS (Basic) | $-0.43 | $2.96 | $5.52 | $9.13 | $3.24 | $-19.14 | $-2.04 | — |
| EPS (Diluted) | $-0.43 | $2.70 | $5.00 | $8.31 | $3.22 | $-19.14 | $-2.04 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.8B | $6.0B | $6.0B | $5.6B | $4.9B | $4.7B | $6.5B | — |
| Current Assets | $1.6B | $1.8B | $2.0B | $2.4B | $1.8B | $1.4B | $1.6B | — |
| Cash & Equivalents | $0.6B | $0.7B | $1.0B | $1.3B | $1.0B | $0.7B | $0.7B | — |
| Total Liabilities | $2.2B | $2.2B | $2.4B | $2.3B | $3.1B | $3.7B | $3.9B | — |
| Current Liabilities | $0.8B | $0.8B | $1.0B | $0.9B | $0.9B | $0.8B | $1.0B | — |
| Stockholders' Equity | $3.5B | $3.7B | $3.5B | $3.2B | $1.8B | $0.9B | $2.6B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.6B | $1.0B | $1.2B | $0.4B | $-0.0B | $0.7B | — |
| Investing Cash Flow | $-0.3B | $-0.6B | $-0.3B | $-0.0B | $-0.1B | $-0.2B | $-0.3B | — |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | — |
| Financing Cash Flow | $-0.1B | $-0.3B | $-0.5B | $-0.7B | $-0.0B | $0.2B | $-0.7B | — |